MDMA is a synthetic compound that increases the release of hormones associated with trust and bonding while decreasing activity in the brain associated with fear and traumatic memory. The user, rather than reliving trauma and remaining paralyzed by it, can instead process and make peace with the trauma in a supportive, trusting environment. It is to be distinguished from street drugs “Ecstasy” or “Molly” both of which often contain other chemicals that can cause harm.
Saj Razvi, MA, LPC
Executive Director, Trauma Dynamics
Sub-investigator MAPS study on MDMA-assisted psychotherapy for treatment resistant PTSD in Boulder
Marcela Ot’alora G, MA, LPC
Principal Investigator for MAPS study on MDMA-assisted psychotherapy for treatment resistant PTSD in Boulder
How can MDMA-assisted psychotherapy support rapid healing for clients diagnosed with treatment-resistant PTSD? Saj Razvi, MA, LPC, describes the process.
How effective is MDMA-assisted psychotherapy compared to the anti-depressants? Saj Razvi, MA, LPC, looks to the MAPS Phase 2 clinical trials for people with treatment-resistant PTSD.
How do MDMA and the support of a psychotherapist work together? Saj Razvi, MA, LPC, explains how the healing happens.
Does MDMA-assisted psychotherapy help heal PTSD? Saj Razvi, MA, LPC, explains how and why MDMA goes beyond symptom management for PTSD to facilitate rapid benefits.
Saj on the study.
Psychotherapist Marcela Ot’alora G on treating PTSD with MDMA.